Evolent Health, Inc.(EVH)— Stock Profile, AI Score & Financials

Technology · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Evolent Health, Inc. (EVH) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores EVH at 26.8/100 on a 32-signal composite quality model, placing it at rank #2,609 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (9.9) and revenue growth (12.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Evolent Health, Inc. reports quarterly revenue of $652.5M, net income of $-28.4M. Top institutional holders of EVH by reported 13-F value include LINDEN ADVISORS, BlackRock, Context Capital Management, based on the most recent SEC filings. EVH trades on the NYSE exchange and files with the SEC under CIK 1628908. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EVH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Evolent Health, Inc. directly from SEC EDGAR.

AI Quality Score

26.8/100

AI Rank

#2,609

Revenue

$652.5M

Net Income

$-28.4M

EVH key financials by period

Evolent Health, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$1.9B$-534.5M-21.9%
FY 202410-K$2.6B$-61.6M-1.6%
FY 202310-K$2.0B$-113.0M-3.6%
FY 202210-K$1.4B$-19.2M0.3%
FY 202110-K$908.0M$-37.6M-4.7%
FY 202010-K$924.6M$-334.2M-28.4%

Institutions holding EVH

Institutional investors reporting a position in Evolent Health, Inc. on SEC Form 13F.
InstitutionSharesValueReported
LINDEN ADVISORS128,850,000$96.3M2026-06-30
BlackRock14,814,851$80.3M2026-06-30
Context Capital Management79,871,000$59.6M2026-06-30
CADIAN CAPITAL MANAGEMENT10,814,473$58.6M2026-06-30
MORGAN STANLEY8,969,012$48.6M2026-06-30
UBS Group AG6,245,283$33.8M2026-06-30
Rubicon Founders5,816,123$31.5M2026-06-30
PenderFund Capital Management Ltd.42,017,000$31.5M2026-06-30
Engaged Capital5,563,912$30.2M2026-06-30
D. E. Shaw5,107,561$27.7M2026-06-30
SEC EDGAR: CIK 1628908 →
EVH

Evolent Health, Inc.

EVH
NYSESmall CapTechnology

13F Pro Quality Score

26.8/100

Rank #2,609 of 2,961 stocks

View Technology peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

12.1/100

Profitability

13.8/100

Balance Sheet

9.9/100

Earnings Quality

22.6/100

Free Cash Flow

34.4/100

Institutional Flow

28.3/100

Revenue Scale

64.1/100

Dilution Risk

39.1/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$652.52M

Net Income

Q2 2026
EDGAR

$-28.36M

EPS (Diluted)

Q2 2026
EDGAR

$-0.25

ROIC

Q2 2026
EDGAR

-2.8%

Debt/Equity

Q2 2026
EDGAR

2.52

Top Institutional Holders

as of Q2 2026
$1.03B total
LINDEN ADVISORS LP
$96.28M+844.0%
BlackRock, Inc.
$80.30M+147.9%
Context Capital Management, LLC
$59.60M+1191.6%
CADIAN CAPITAL MANAGEMENT, LP
$58.61M0.0%
MORGAN STANLEY
$48.61M+455.4%
UBS Group AG
$33.85M-23.4%
Rubicon Founders LLC
$31.52M0.0%
PenderFund Capital Management Ltd.
$31.48M+171.1%
Engaged Capital LLC
$30.16M0.0%
D. E. Shaw & Co., Inc.
$27.68M-74.7%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…